Google’s GV and al­lies dou­ble down on Forty Sev­en with their sec­ond $75M round

One of the most ad­vanced, well-fi­nanced biotechs in the Bay Area just land­ed a $75 mil­lion B round to con­tin­ue its clin­i­cal work.

Forty Sev­en, a start­up that was spun out of Irv Weiss­man’s lab at Stan­ford, dou­bled down on the sim­i­lar-sized A round from last year, with Google’s ven­ture arm GV com­ing back along­side new in­vestor Welling­ton Man­age­ment Com­pa­ny LLP, with par­tic­i­pa­tion from ex­ist­ing in­vestors Clarus, Light­speed Ven­ture Part­ners and Sut­ter Hill Ven­tures.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER